Denosumab versus intravenous bisphosphonate use for hypercalcemia in multiple myeloma.

Authors :: Lei MM
Tavares E
Buzgo E
Lou U
Raje N
Yee AJ
Source :: Leukemia & lymphoma [Leuk Lymphoma] 2022 Dec; Vol. 63 (13), pp. 3249-3252. Date of Electronic Publication: 2022 Aug 29.
Publication Year :: 2022

Subjects :: Humans
Diphosphonates adverse effects
Denosumab adverse effects
Hypercalcemia diagnosis
Hypercalcemia drug therapy
Hypercalcemia etiology
Multiple Myeloma complications
Multiple Myeloma diagnosis
Multiple Myeloma drug therapy
Bone Density Conservation Agents adverse effects
Bone Neoplasms

Full Text Access

Tools